Reuters: Health News: Hemispherx says FDA rejects fatigue drug application

Hemispherx says FDA rejects fatigue drug application

(Reuters) - Hemispherx Biopharma Inc said U.S. regulators had declined to approve its new drug application for Ampligen, its experimental drug for tre...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/_qhboq7vhy8/us-hemispherxbiopharma-fda-ampligen-idUSBRE91404320130205